Status:
ENROLLING_BY_INVITATION
Electroporation for Treatment of Atrial Fibrillation
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Persistent Atrial Fibrillation
Longstanding Persistent Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Comparison of pulmonary vein and left atrial posterior wall isolation durability and clinical outcome between radiofrequency and pulse field ablation in patients with persistent and longstanding persi...
Detailed Description
Patients with persistent and longstanding persistent atrial fibrillation will be randomized to control and investigational group. In control group they will receive pulmonary vein and posterior wall ...
Eligibility Criteria
Inclusion
- atrial fibrillation recorded with 12-lead ECG, holter ECG or implantable device on two occasions at least one week apart
Exclusion
- history of previous catheter ablation, history of previous heart surgery, life expectancy less than one year, any lifethreatening severe acute condition, acute deep venous thrombosis, presence of intracardiac masses or thrombi.
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06134752
Start Date
December 5 2023
End Date
May 1 2027
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Surgery Department, University Medical Centre Ljubljana
Ljubljana, Slovenia, 1000